SBIO
ALPS Medical Breakthroughs ETF · PSE
- Category Health Care
- Expense Ratio 0.5%
- Listing Date
- Volume 34,492.0
- Market Cap (AUM) $81.57M
Performance
-3.63%
1W
+6.41%
1M
-1.21%
3M
-13.41%
6M
-8.53%
YTD
-5.31%
1Y
Top Holdings
-
Name
Symbol%Assets
- Vaxcyte, Inc.PCVX5.55%
- Cerevel Therapeutics Holdings IncCERE5.34%
- Revolution Medicines, Inc.RVMD4.36%
- Summit Therapeutics IncSMMT3.86%
- Viking Therapeutics, Inc.VKTX3.73%
- Alkermes Public Limited CompanyALKS2.95%
- Axsome Therapeutics, Inc.AXSM2.51%
- Crinetics Pharmaceuticals IncCRNX2.43%
- Merus N.V.MRUS2.20%
- Corcept Therapeutics Incorporated.CORT2.15%
Technical Analysis of SBIO 2025-06-18
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-05-19 08:13
Healthcare Innovation Alive & Well in SBIO(ETF Trends)
- 2025-05-01 15:25
Aim To Keep Risk Modest And Quality High(Seekingalpha)
- 2025-04-29 16:35
3 Ways To Avoid The Eye Of The Equity Market Storm(Seekingalpha)
- 2025-04-22 17:45
Rewiring Global Trade For Resilience And Growth(Seekingalpha)
- 2025-04-18 01:40
- 2025-04-03 20:30
- 2025-04-01 19:00
The Great Transformation: Riding The Wave Of Change(Seekingalpha)
- 2025-03-31 17:40
- 2025-03-27 18:05
Volatility Brings Changes To Market Leadership(Seekingalpha)
- 2025-03-20 04:32
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.